ported by Sir James Paget in 1874, the condition later of Paget's disease treated in this manner. 11, 12 Therefore, the authors collectively reviewed their experience termed Paget's disease of the nipple has been a well documented clinical entity. 1 The description of clinical using definitive radiotherapy in the management of Paget's disease presenting as nipple changes in the changes of the nipple and areola described by Sir Paget as having the ''. . . appearance of a florid intensely absence of a palpable mass or a mammographic density, and report the local control and disease specific red raw surface; very finely granular, as if the whole thickness of the epidermis were removed; like the sursurvival achieved with a breast-conserving approach. face of very acute diffuse eczema . . . (with) cancer of the mammary gland (following) within at the most two
MATERIALS AND METHODS

Patient Eligibility
years and usually within one year . . .'' remains as accurate a description today as when initially deTo generate a series of patients treated with limited surgery and breast radiotherapy for Paget's disease, scribed.
Paget's disease of the breast occurs in approxiclinical cases were combined from seven institutions into a single data base at the University of Michigan. mately 1-3% of all primary breast carcinoma series [2] [3] [4] and most often presents clinically as eczematous Thirty cases of Paget's disease of the nipple without a palpable mass or mammographic density treated with changes of the nipple, associated with bleeding, itching, and ulceration.
2, 5 Although approximately 50% of definitive radiotherapy were identified from the following institutions: six cases each from the University patients also present with an associated palpable mass elsewhere in the breast, 40 -50% of patients are diagof Michigan and Yale University, five cases from the University of Pennsylvania, four cases each from Menosed with Paget's disease without a clinically detectable breast lesion.
2,3, 6 In recent studies in which mammorial Sloan-Kettering Cancer Center and William Beaumont Hospital, three cases from Tufts University, mographic findings have been correlated with clinical findings, the majority of women presenting with nipand two cases from the Joint Center for Radiation Therapy. All patients were treated with breast conserple changes in the absence of a palpable mass have had negative mammographic findings as well, 7 with vation based on patient preference. No patients were referred for radiotherapy due to medical contraindicanegative mammograms reported in 63% of women presenting only with nipple changes in 1 series. 7 tions to surgery.
Twenty-nine women were diagnosed with AJCC Pathologically, all patients with Paget's disease have characteristic round intraepidermal cells of the clinical Tis N0 M0, Stage 0 Paget's disease of the breast; one patient with Paget's disease of the nipple was diagnipple. However, variable pathologic findings have been reported in the remainder of the breast, depennosed with clinical T1N0M0, Stage I disease due to a focus of microinvasion. 13 All patients were treated dent primarily on the presence or absence of a breast mass. An underlying breast malignancy has been docbetween 1980 -1994. Each patient had a nipple biopsy demonstrating large, pale, rounded, or ovoid intraeumented in 96 -100% of cases when breast specimens have been analyzed after mastectomy. Historically, the standard local therapy for Paget's total nipple excision, 13% (4 of 30) underwent partial nipple excision, and 63% (19 of 30) and 7% (2 of 30) disease has been mastectomy.
2,3,5 However, with the highly favorable prognosis of Paget's disease in the underwent total and partial nipple-areolar excision, respectively. Two patients (7%) underwent biopsy only absence of a breast mass, and the increasing reports of the successful use of conservative surgery and radiowithout resection of the nipple. Fourteen patients (47%) had a reexcision performed and 15 (50%) were therapy in the treatment of DCIS of the breast, 9, 10 interest in a breast-conserving option has been generated. not reexcised; the use of reexcision was unknown in 1 patient (3%). Final margins were negative in 16 cases However, limited data exist concerning the outcome / 7b61$$1308 08-20-97 22:39:30 canxa W: Cancer (53%), positive in 2 (7%), and unknown in 12 (40%). whether it was isolated or concurrent with regional and/or distant failure. Patients were scored as being Eleven women (37%) had an axillary lymph node dissection, with a median of 13 lymph nodes removed without evidence of disease (NED) at last observation if they had been continuously free of disease from the (range, 8 -24 lymph nodes). All lymph nodes were pathologically negative for metastatic disease.
completion of radiotherapy to the last follow-up visit or had developed local and/or regional failure that was successfully salvaged at the last observation period. Radiotherapy All patients received external beam radiotherapy to For the calculation of cause specific survival, only deaths secondary to breast carcinoma were scored as the breast using tangential irradiation. The median dose to the entire breast was 50 grays (Gy) (range, 45 -events. For the calculation of overall survival, all deaths were scored as events. 54 Gy). The median fraction size was 2 Gy (range, 1.8 -2 Gy). Dose distributions were reviewed for intentional Univariate analyses were performed using Fisher's exact test to evaluate the strength of association beunderwedging at the nipple-areolar region. Six plans were intentionally underwedged to generate an area of tween clinical characteristics and local control. The small sample sizes and number of events in this series increased dose in the nipple-areolar area. The median isodose of these plans was 110% (range, 106 -110%).
precluded performing a meaningful multivariate analysis. A boost was delivered to the remaining nipple or tumor bed in 97% of cases (29 of 30) to a median dose of 14 Gy (range, 9 -20 Gy). The median total dose to The median age at diagnosis was 50 years (range, 35 -treated with electrons, and 3% (1 of 29) each were 79 years). Thirteen patients (43%) were premenotreated using 100-kilovault photons, cobalt, or a doupausal, 16 (53%) were postmenopausal, and 1 patient ble-plane iridium implant. One patient was treated (3%) was perimenopausal when diagnosed. The prewith a boost of unknown type. Bolus was used in the senting symptoms at the nipple-areolar complex were photon and/or electron portion of treatment in 33% as follows: 67% of patients (20 of 30) presented with of cases (10 of 30), not used in 60% (18 of 30) of cases, nipple pain, itching and/or scaling; 37% (11 of 30) and unknown in 7% of cases. Of the ten patients who presented with nipple discharge; 20% (6 of 30) prewere treated with bolus, bolus was applied to the resented with nipple erythema; and 17% (5 of 30) premaining nipple-areolar complex daily in six, two were sented with nipple ulceration. No patients were bolused to the remaining scar, and two received bolus asymptomatic at presentation. The median duration to the entire breast for a portion of the external beam of symptoms was 8.5 months (range, 1 -36 months). treatment. In addition to breast irradiation, 1 patient Twenty-nine of 30 patients (97%) underwent a received supraclavicular radiotherapy to a dose of 46 mammogram at presentation. Twenty-four of 29 Gy and a second patient was treated comprehensively mammograms were read as negative for malignancy. to the supraclavicular, axillary, and internal mammary Of the remaining five studies in which mammographic lymph nodes to a total dose of 50 Gy. One patient changes were noted, findings included two with retroreceived systemic treatment with tamoxifen. areolar calcifications, two with nonspecific calcifications, and one with suspicious calcifications elsewhere Data Analysis in the breast. Three of these mammograms also inPatient records were reviewed for the following charcluded results suggestive of nipple thickening. There acteristics: age, menopausal status, presenting sympwere no mammographic findings suspicious for a toms, duration of symptoms, mammographic findbreast mass. ings, extent of surgical excision, final margin status, Two patients underwent an incisional biopsy of pathologic findings, dissection of the axillary lymph the nipple only; the remaining 28 patients underwent nodes, and the results of the dissection if performed.
either partial or complete excision of the nipple or Actuarial curves for local control, survival free of disnipple-areolar complex, as outlined earlier. Pathologic ease, and overall survival were generated using the review revealed Paget's cells of the nipple in all 30 Kaplan -Meier method, measured from the complecases. In addition to the presence of the Paget's cells, tion of radiotherapy.
14 A local failure as only first fail-DCIS was identified in 23 of the biopsy specimens ure was defined as a patient who recurred in the breast (77%), and DCIS with a single focus of microinvasion without preceding or simultaneous regional or distant was found in 1 specimen (3% for pathologic assessment or had no DCIS or invasion prior to radiotherapy. Persistent calcifications led to a present. subsequent biopsy 4 years later that confirmed residual DCIS. She had focal intraductal carcinoma only in Locoregional Control the mastectomy specimen. Another patient had With a median follow-up of 62 months for surviving multifocal DCIS in the mastectomy specimen, and the patients (range, 13 -176 months), 3 patients (10%) had third had both invasive and noninvasive disease. developed a recurrence in the breast as the only site Of the two additional patients with a local recurof first failure (Fig. 1) . The 5-and 8-year actuarial local rence as a component of first failure, one experienced control rates for a breast failure as the only site of first a simulataneous breast and axillary lymph node failfailure were 91% (95% confidence interval [CI] 80 -ure, and the second had a breast and distant (contra-100%) and 84% (95% CI, 69 -100%), respectively. Two lateral axillary) lymph node failure. Both local recuradditional patients developed a breast failure simultarences were detected by both physical examination neously with regional or distant failure; the cumulative and mammogram and pathologically contained inva-5-and 8-year actuarial control rates for a breast recursive and intraductal disease. The former patient was rence as component of first failure were 91% (95% CI, treated by mastectomy; 6 of 19 lymph nodes were 80 -100%) and 77% (95% CI, 59 -100%), respectively.
found to contain metastatic disease. The patient subFor those who experienced a breast recurrence, the sequently received 6 cycles of cyclophosphamide, doxmedian time to local failure was 69 months (range, orubicin, and 5-fluorouracil, followed by tamoxifen, 21 -122 months). Despite treatment to the axilla in and at last follow-up was free of disease 64 months only 12 of 30 patients (40%) (i.e., 11 with axillary lymph after recurrence. The patient with simultaneous local node dissection and 1 with comprehensive regional and distant failure recurred 10 years and 6 months irradiation) only 1 patient developed a clinical ipsilatafter therapy to the breast. At the time of recurrence, eral axillary lymph node failure (3%), which was surgionly a biopsy was performed of the treated breast; no cally salvaged. She had not undergone previous axilattempt was made to perform a mastectomy. Thus, 29 lary surgery or radiotherapy.
of 30 patients (97%) were ultimately locally controlled All three recurrences in patients with breast-only by either primary treatment or salvage surgery at last failures as first failure were detected by mammogram follow-up. The actuarial rates of local control includonly and successfully salvaged by mastectomy. One of ing surgical salvage at 5 and 8 years were 100% and these three patients had residual microcalcifications on a postbiopsy mammogram that were not excised 100%, respectively, as shown in 100%). The cause specific survival rate at both 5 and 8 years was 100%.
Cosmesis and Complications
local recurrence for which salvage was not attempted occurred beyond the last point of actuarial analysis.) The cosmetic result was assessed by the treating radiation oncologist in 24 patients using the criteria preUnivariate analysis for local failure as component of first failure was performed for the following factors:
viously suggested by Harris et al. 15 Nine of 24 patients (38%) were believed to have an excellent result, 13 mammographic findings, extent of nipple/nipple-areolar complex resection (complete nipple/nipple-areo-(54%) a good result, and 2 (8%) a fair result. The cosmetic result did not vary significantly by the extent of lar excision vs. partial nipple/nipple-areolar excision), pathologic results in the lumpectomy specimen (Pagthe resection (data not shown); however, three of the patients with good to excellent results underwent nipet's cells only vs. DCIS with or without microinvasion), final margin status, whole breast dose (õ 50 Gy vs. ¢ ple reconstruction after complete nipple-areolar resection. 50 Gy), total tumor bed dose (õ 60 Gy vs. ¢ 60 Gy), and the use of bolus. No factors emerged as statistically
The incidence of complications was assessed in 27 of 30 cases. No complications were reported in 89% significant predictors of local failure at the conventional level (P°0.05), Table 1 . However, there was a of the patients reviewed (24 women). One patient each developed protracted chest wall pain (4%), chronic trend toward improved local control in patients treated with total nipple/nipple-areolar excision (3 breast infection treated with antibiotics (4%), and a questionable radiation dermatitis treated with steroids failures in 22 patients; 14%) compared with partial nipple/nipple-areolar excision (2 failures in 6 patients; (4%). 33%) (P Å 0.29).
DISCUSSION
The purpose of this study was to present the local
NED Survival and Overall Survival
At last follow-up, two patients were alive with distant control and survival rates for a consecutive series of patients treated with conservative surgery and radiodisease. The NED survival rate at 5 and 8 years was / 7b61$$1308 08-20-97 22:39:30 canxa W: Cancer therapy for Paget's disease of the nipple, and to conwere treated with supervoltage techniques with a follow-up ranging from 11 months to nearly 14 years trast these results with historic controls treated with mastectomy. The clinical characteristics of the pa-(median, 66 months). Of note, these patients usually were treated with biopsy alone, followed by irradiation tients in the current study are comparable to those described in mastectomy series. The median age at limited to the central portion of the breast. In the current series, 2 patients have developed distant disease, diagnosis was 50 years, consistent with surgical series, 3, 5, 16 and all patients presented with clinical resulting in 5-and 8-year distant disease free survivals of 95%. Therefore, although the results of breast-conchanges at the nipple typical of Paget's disease, including pruritis, erythema, and mild ulceration. The meserving therapy using radiotherapy cannot be definitively compared with those obtained using mastecdian duration of symptoms prior to diagnosis was 8.5 months, which is also in agreement with mastectomy tomy in the absence of a randomized trial, these retrospective analyses suggest similar distant disease free series, in which the diagnosis often has been delayed secondary to the presumption of benign skin disease.
results for the two treatment modalities and encourage consideration of a conservative approach for selected In general, the prognosis after mastectomy in the absence of a palpable mass has been very favorable, patients with Paget's disease of the nipple. Although the presence of the intraepidermal Pagwith some series reporting no deaths secondary to carcinoma at 5 years.
2 However, others have reported inet's cell is the pathologic hallmark of the disease, the histogenesis of the Paget's cell is controversial. Two vasive recurrences after mastectomy. In a series of 37 patients with Paget's disease of the nipple without a theories have been proposed to account for the pathogenesis of the disease. 17 The first theory, the epidermopalpable mass treated with simple mastectomy, Dixon et al. reported a 5% incidence of invasive recurrence tropic theory, suggests that Paget's cells are derived from ductal epithelium and are essentially DCIS cells with a 40-month median follow-up. 4 Thus, although distant disease free survival exceeds 90 -95% in pathat have migrated to the epidermis by way of the lactiferous ducts. The second theory, the transformatients with Paget's disease without a palpable mass treated with ablative surgery, mastectomy does not tion theory, proposes that Paget's cells are transformed in situ keratinocytes of the epidermis of the uniformly result in survival free of disease.
Limited experiences using breast-conserving surnipple and represent a malignant process independent of the underlying breast parenchyma. Light microsgery followed by definitive radiotherapy have produced results similar to those reported after masteccopy studies have produced evidence supporting both theories, but immunohistochemical studies have fatomy. Fourquet et al. from the Institut Curie retrospectively examined 20 patients with Paget's disease vored a mammary origin for Paget's cells. 18-20 Studies using different monoclonal antibodies against low mowithout a detectable mass treated at a single institution. 11 Seventeen patients underwent biopsy only, lecular weight epithelial keratins, such as keratins 8, 18 , and 19 have demonstrated their presence in large whereas 3 underwent excision of the nipple or nipple and areola prior to radiotherapy. The median dose amounts in Paget's cells and their absence in surrounding keratinocytes, characteristic of cells of nordelivered to the breast was 57 Gy, with a boost given to 90% of patients to a median total dose of 72 Gy to mal luminal mammary epithelium. 8 More recent studies have demonstrated concordance of immunoreacthe tumor site (range, 55 -83 Gy). With a median follow-up of 90 months, 15% of failures recurred in the tivity in the Paget's cells and the underlying carcinoma, including almost identical immunohistobreast only, and were successfully salvaged by mastectomy. All three failures were in patients who did not chemical staining profiles with antibody 21N, which was raised against a peptide from the C-terminus of undergo complete excision of the lesion. There were no deaths due to breast carcinoma. Bulens et al. re- the predicted sequence of the c-erb B-2 product.
19,20
Thus, most evidence strongly supports the epidermoported a series of 13 patients treated conservatively in Leuven, Belgium. 12 Disease was limited to the nipple tropic theory of an underlying carcinoma; however, rare cases of Paget's disease in which an underlying or skin without evidence of an underlying tumor. Patients underwent biopsy without an attempt at comcarcinoma cannot be detected histologically still prompt consideration of the in situ transformation plete excision. The entire breast received 30 to 65 Gy, with a boost to the tumor bed for a total dose of 60 -theory. The origin of the Paget's cell has implications for 70 Gy. At a median follow-up of 52 months, there were no local or distant failures. A series from Guildford, treatment. If the Paget's cell originated de novo in the nipple epithelium, simple resection of the nippleEngland included patients treated over a long period with varying presentations and therapy. 16 There was 1 areolar complex followed by no additional therapy to the remaining breast parenchyma might be an approlocal failure at 38 months among the 8 patients who / 7b61$$1308 08-20-97 22:39:30 canxa W: Cancer priate therapeutic alternative. However, the presence year actuarial rates of local failure were 6% and 16%, respectively. Rates of surgical salvage were similar beof an underlying breast malignancy would necessitate treatment to the residual breast tissue. Attempts of tween the series reported by Solin et al. 23 and the current series, with 86% and 80% (4 of 5) of the local nipple-only excision, as suggested by the transformation theory, have produced varying results. In a small recurrences, respectively, salvaged by additional treatment. In addition, the long term rates of survival free series reported by Lagios et al. from San Francisco, 1 of 5 patients treated with complete or partial nipplefrom distant metastases were comparable between the two series, with the study by Solin et al. 23 reporting a areolar excision in the absence of a palpable mass or any suspicious mammographic finding recurred lo-10-year actuarial rate of freedom from distant failure of 96% versus 95% at 8 years in the current study. cally at 12 months. 21 This patient (initially treated with partial nipple-areolar excision) recurred in the residual Because DCIS represents the predominant underlying malignancy in the breast of patients with Paget's disareolar skin. She was salvaged with reexcision, and all patients remained free of disease with an average of ease without a palpable mass, it is understandable that the local control rate and distant disease free survival 50 months of follow-up (range, 30 -69 months). Paone and Baker at the Johns Hopkins Hospital reported that for conservatively managed Paget's disease treated with radiotherapy would parallel the results achieved none of the five patients with Paget's disease presenting in the absence of a palpable mass recurred after for DCIS. The authors believe treatment of Paget's disease nipple excision and wedge resection of underlying breast tissue 5 ; however, the length of follow-up was should include excision of the entire nipple-areolar complex with negative microscopic margins, and all not specified. Dixon et al. in Nottingham, United Kingdom presented the outcome of ten patients with Pagsuspicious microcalcifications demonstrated on a pretreatment mammogram, as confirmed by a negative et's disease presenting in the absence of a palpable mass with mammographic changes suggesting in situ postbiopsy mammogram. 24 Although the current series does not have the statistical power to detect a changes only immediately adjacent to the nipple who were treated with excision of the nipple-areolar comsignificant impact of complete excision of the nippleareolar complex or margin status on local control, implex with a cone of underlying breast tissue. 4 Despite all patients having negative microscopic deep resecproved control with complete excision and negative margins is consistent with treatment guidelines for tion margins, 40% (4 of 10) developed a local failure at 8 -19 months after surgery. Three of the four patients DCIS, in which all areas of potential disease are excised prior to definitive radiotherapy. recurred with invasive disease; two developed distant metastases, with one death from disease. A recent abAlthough, to the authors' knowledge, this series is the largest report of patients with Paget's disease of stract from Memorial Sloan-Kettering Cancer Center described five patients with Paget's disease with no the nipple treated with breast-conserving surgery and radiotherapy, the number of patients and the number evidence of invasion treated with a central quadrantectomy including removal of the nipple, and microof events in the current collective series is small. Other limitations include the lack of a central pathologic and scopically negative margins; three recurred locally.
22
Although the first two series may be consistent with imaging review due to the unavailability of all pathologic and mammographic studies. Thus, additional sethe in situ transformation theory of the histopathogenesis of the Paget's cell, the latter two series strongly ries are needed to confirm the findings of the current study. However, this study demonstrates the successsupport the epidermotropic theory and demonstrate the importance of treatment to the underlying breast ful results using breast-conserving treatment as an alternative to mastectomy. High rates of disease free and in patients with Paget's presenting with in situ disease even in the presence of negative margins.
overall survival, in addition to adequate local control, justify consideration of a conservative approach when The current study reports the 5-and and 8-year actuarial breast recurrence rates to be 9% and 16%, presenting management options to women with Paget's disease of the nipple presenting in the absence of respectively, when local failure as only site of first failure is calculated. These estimates of breast failure are a palpable mass or mammographic density. consistent with those reported for DCIS treated definitively with radiotherapy. The National Surgical Adju-
